BRIEF published on 05/12/2025 at 07:35, 1 year ago Promising data for MaaT033 in ALS Microbiome Amyotrophic Lateral Sclerosis MaaT033 Safety And Tolerability Phase 1b Clinical Trial
BRIEF published on 04/08/2025 at 07:35, 1 year 2 months ago MaaT Pharma Announces Positive Interim Safety Results for MaaT033 Phase 2B Trial MaaT Pharma MaaT033 Allo-HSCT DSM Safety
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 2 months ago Inside Information / Other news releases MaaT Pharma announces positive safety interim analysis from DSMB for Phase 2b trial evaluating MaaT033 for patients receiving Allo-HSCT, demonstrating favorable safety profile and tolerability Phase 2B Trial MaaT Pharma Safety Analysis MaaT033 Allo-HSCT
BRIEF published on 04/07/2025 at 07:35, 1 year 2 months ago MaaT Pharma: New cover by HC Wainwright & Co Cancer Euronext Listing Microbiome Ecosystem Therapies MaaT Pharma HC Wainwright & Co
BRIEF published on 03/27/2025 at 07:35, 1 year 2 months ago MaaT Pharma announces a capital increase of 13 million euros and 2024 annual results Financial Results Biotechnology Capital Increase MaaT013 AGvH
BRIEF published on 01/21/2025 at 18:05, 1 year 4 months ago Positive Results for MaaT033 Clinical Trial Biotechnology Security Oncology Clinical Trial MaaT033
PRESS RELEASE published on 12/10/2024 at 02:30, 1 year 6 months ago Inside Information / Other news releases
BRIEF published on 10/15/2024 at 07:35, 1 year 7 months ago MaaT Pharma Clinical Trial Recruitment Concluded Clinical Trial MaaT Pharma MaaT013 DSMB Notice AGvH Treatment
PRESS RELEASE published on 10/15/2024 at 07:30, 1 year 7 months ago Inside Information / Other news releases MaaT Pharma completes recruitment of its ARES Phase 3 Trial for MaaT013, a treatment for Acute Graft-versus-Host Disease, with topline results expected in January 2025 Clinical Trial MaaT Pharma MaaT013 ARES Phase 3 Trial Acute Graft-versus-Host Disease
BRIEF published on 09/04/2024 at 07:35, 1 year 9 months ago MaaT Pharma Announces Participation in Investor and Medical Conferences in September Investors Cancers Medical Conference MET Therapies Cell Transplantation
Published on 06/10/2026 at 00:00, 2 hours 45 minutes ago Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Published on 06/09/2026 at 23:00, 3 hours 45 minutes ago NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/09/2026 at 22:30, 4 hours 15 minutes ago Gamma Resources Announces Receipt of $604,500 from Warrant Exercises
Published on 06/09/2026 at 21:45, 5 hours ago Northfield Announces Change of Corporate Name to Juno International Corporation
Published on 06/09/2026 at 15:00, 11 hours 45 minutes ago Worksport Ltd. Reports Additional $50,000 CEO Insider Stock Acquisition, Reinforcing Confidence in Long-Term Value Creation
Published on 06/09/2026 at 22:55, 3 hours 50 minutes ago JACOBS STEPS-UP AS 'OFFICIAL SPONSOR OF STAYING AWAKE' AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT
Published on 06/09/2026 at 22:35, 4 hours 10 minutes ago Eurobattery Minerals publishes Annual Report 2025
Published on 06/09/2026 at 19:32, 7 hours 12 minutes ago 2CRSi SA: 2CRSi announces a €110 million sale of Godì Blackwell Ultra servers in Germany
Published on 06/09/2026 at 19:10, 7 hours 34 minutes ago The 2026 Global Energy Prize shortlist released
Published on 06/09/2026 at 19:10, 7 hours 34 minutes ago THE SULTANATE OF OMAN CONSOLIDATES ITS POSITION AS A STABLE DESTINATION FOR GLOBAL CAPITAL
Published on 06/09/2026 at 19:30, 7 hours 15 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 06/09/2026 at 18:14, 8 hours 31 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2026
Published on 06/09/2026 at 15:17, 11 hours 28 minutes ago Statement of transactions in own shares from June 1, 2026 to June 5, 2026
Published on 06/09/2026 at 10:37, 16 hours 8 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 1 to June 5 2026
Published on 06/09/2026 at 07:00, 19 hours 45 minutes ago New strategic Milestone for Biophytis: Official Establishment of Its Joint Venture in Asia
